Form 4: Fulgent Genetics' Chief Scientific Officer Gao Hanlin Reports Stock Transaction

Gao Hanlin, Chief Scientific Officer of Fulgent Genetics, reports the withholding of shares to cover tax obligations related to vesting restricted stock units.

Summary

• On February 23, 2025, Fulgent Genetics' Chief Scientific Officer, Gao Hanlin, had 417 shares of common stock withheld to satisfy tax obligations.
• The shares were withheld at a price of $16.46 per share.
• This action occurred due to the vesting of restricted stock units granted on February 23, 2023.
• Following the transaction, Gao Hanlin beneficially owns 917,633 shares of Fulgent Genetics common stock directly.

Sentiment

Score: 5

Explanation: This is a neutral event related to standard executive compensation practices and doesn't indicate positive or negative sentiment.

Industry Context

This is a routine filing related to executive compensation and tax obligations, common in publicly traded companies. It doesn't necessarily reflect a change in the company's outlook or performance.

Comparison to Industry Standards

• Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, as mandated by the SEC.
• The tax withholding related to vesting of restricted stock units is a common occurrence in executive compensation packages across the industry.
• Comparable companies like Exact Sciences or Invitae also have similar insider transaction filings.

Key Dates